Kintor Pharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,347	967	420	729	4,408	4,767
Market Cap Growth	80.92%	130.32%	-42.42%	-83.45%	-7.54%	23.39%
Enterprise Value	1,407	1,005	318	319	4,229	2,824
Last Close Price	2.73	1.96	0.97	1.63	9.85	12.30
PS Ratio	37.05	26.60	78.93	-	-	113.46
PB Ratio	6.63	4.76	1.34	1.45	2.61	2.35
P/TBV Ratio	16.07	11.54	2.72	2.14	3.10	2.74
EV/Sales Ratio	38.69	27.64	59.75	-	-	67.22
Debt / Equity Ratio	0.47	0.47	0.45	0.55	0.19	0.10
Net Debt / Equity Ratio	0.30	0.30	-0.05	-0.45	-0.39	-0.54
Net Debt / EBITDA Ratio	-0.38	-0.38	0.12	0.22	0.62	1.08
Net Debt / FCF Ratio	-0.32	-0.32	0.08	0.52	0.60	0.80
Asset Turnover	0.08	0.08	0.01	-	-	0.02
Inventory Turnover	3.45	3.45	-	-	-	-
Quick Ratio	0.28	0.28	0.99	2.07	2.76	4.81
Current Ratio	0.43	0.43	1.03	2.10	4.74	6.94
Return on Equity (ROE)	-83.96%	-83.96%	-41.29%	-108.62%	-60.59%	-53.24%
Return on Assets (ROA)	-25.18%	-25.18%	-12.80%	-40.04%	-29.38%	-26.62%
Return on Capital Employed (ROCE)	-80.90%	-80.90%	-40.70%	-145.30%	-55.80%	-45.20%
Earnings Yield	-16.53%	-23.02%	-39.35%	-160.22%	-24.48%	-21.68%
FCF Yield	-14.08%	-19.61%	-50.83%	-58.95%	-25.36%	-29.03%
Buyback Yield / Dilution	-4.42%	-4.42%	-0.39%	-13.94%	-5.66%	-15.21%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.